Ancora Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-80
| Closed | -$4K | – | 2369 |
|
2021
Q3 | $4K | Sell |
80
-90
| -53% | -$4.5K | ﹤0.01% | 1926 |
|
2021
Q2 | $11K | Sell |
170
-540
| -76% | -$34.9K | ﹤0.01% | 1479 |
|
2021
Q1 | $66K | Sell |
710
-27,309
| -97% | -$2.54M | ﹤0.01% | 958 |
|
2020
Q4 | $2.51M | Buy |
28,019
+10,210
| +57% | +$915K | 0.08% | 228 |
|
2020
Q3 | $1.84M | Sell |
17,809
-14,199
| -44% | -$1.47M | 0.07% | 229 |
|
2020
Q2 | $2.53M | Buy |
32,008
+11,590
| +57% | +$916K | 0.11% | 194 |
|
2020
Q1 | $1.18M | Buy |
20,418
+6,788
| +50% | +$393K | 0.05% | 290 |
|
2019
Q4 | $735K | Buy |
13,630
+330
| +2% | +$17.8K | 0.03% | 433 |
|
2019
Q3 | $695K | Buy |
+13,300
| New | +$695K | 0.03% | 394 |
|